CRT 2017 : VALVE & STRUCTURAL - TRICUSPID: Tricuspid Valve New Frontiers

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$24.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

VALVE & STRUCTURAL - TRICUSPID: Tricuspid Valve New Frontiers

Featuring

  • JoAnn Lindenfeld
  • Adam Greenbaum
  • Steven Bolling
  • Rebecca Hahn
  • Charles Davidson
  • Ramon Quesada
  • Azeem Latib
  • Francesco Maisano
  • Danny Dvir

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$24.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Natural History of Functional Tricuspid Regurgitation: Primary Versus Secondary TR - JoAnn Lindenfeld
Transcatheter Tricuspid Valve Repair: Available Techniques and Patient Selection Criteria - Adam Greenbaum
Indications for and Outcomes of Surgical Management of Tricuspid Valve Disease - Steven Bolling
Intra-Procedural Guidance for Transcatheter Tricuspid Valve Devices - Rebecca Hahn
Edwards Transcatheter Approach to Tricuspid Regurgitation - Rebecca Hahn
Initial Experience With Trialign for Functional Tricuspid Regurgitation - Charles Davidson
Transcatheter Therapy for Severe TR Heterotopic Valve Implant - Ramon Quesada
Mitral Clip for Tricuspid Regurgitation - Azeem Latib
Cardioband for Tricuspid Regurgitation - Francesco Maisano
Tricuspid Valve-In-Valve Implantation - Danny Dvir
Transcatheter Treatment of Tricuspid Regurgitation: Experience With the FORMA Device - Rebecca Hahn
Initial Experience With TriCinch (4Tech) - Francesco Maisano

Target Audience

Learning Objectives

Related Moments

Twelve Months Dual Antiplatelet Therapy after Drug-eluting Stents – Too Long, too Short or Just Right?
Journal
Article on Twelve Months Dual Antiplatelet Therapy after Drug-eluting Stents – Too Long, too Short or Just Right?
Pharmacological Treatment Of Patients With Chronic Systolic Heart Failure
Journal
Article on Pharmacological Treatment Of Patients With Chronic Systolic Heart Failure
The FUTURE Study - Scientific Review
Roundtable
FUTURE is a French open label, randomized clinical trial designed to test the superiority of FFR against angiography guided revascularization. Some of the early outcomes of the study were reported...
Supported By
Loading Simple Education